CClinicalTrials.gg
CompletedNCT02291159Updated Dec 31, 2014

Effects of DNHS Technique in the Treatment of Upper Limb Spasticity and Function in Stroke

An interventional study of DNHS ® (Dry Needling for Hypertonia and Spasticity) and Sham Dry Needling in Stroke and Spasticity, sponsored by Universidad San Jorge. Completed at 1 site in Spain. Open to participants aged 40 Years to 85 Years. Per ClinicalTrials.gov, last updated 2014-12-31.

Sponsored by Universidad San Jorge · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Randomized
Ages
40 Years to 85 Years
Sex
All
01

Study summary

Introduction: Stroke is a neurological deficit caused by a decrease in cerebral blood flow. The DNHS ® (Dry Needling for hypertonia and Spasticity) technique is a dry needling technique to reduce spasticity and hypertonia and improve function in patients with CNS injury. The main objective of this trial is to analyze the therapeutic effect of DNHS® technique in motor function in patients between 45 and 80 in a chronic state after a stroke. Methods: Double-blinded randomized clinical trial. There will be an intervention group (DNHS® technique) and a sham control group. The intervention will be 2 sessions, one per week, in biceps brachii, brachialis, flexor digitorum superficialis nad profundus, adductor pollicis and first dorsal interossei. The Fugl Meyer Assessment Scale, Modified Ashworth Scale and Stroke Impact Scale will be used as outcome measures. The data will be expressed as mean ± (Standard Deviation). The standardized difference or effect size (ES, 90% confidence limit) in the selected variables will be calculated.

02

Conditions studied

  • Stroke
  • Spasticity

Keywords

  • stroke
  • spasticity
  • dry needling
  • upper motor neuron syndrome
  • motor function
03

In context

Muscle Spasticity

704 studies on the registry are indexed under Muscle Spasticity; 149 are open to participants now.

This study's enrollment of 10 is below the median of 36 across 525 interventional studies indexed under Muscle Spasticity.

Browse Muscle Spasticity studies →

Lead sponsor

Universidad San Jorge is the lead sponsor of 32 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • people aged 40-85 years with hemiplegia resulting from stroke of more than 6 months evolution (chronic stroke)
  • ability to follow instructions and reply to assessment questonnaires

Exclusion criteria

Exclusion Criteria:

  • recurrent stroke episodes
  • other concomitant neurodegenerative conditions
  • fear to needles
  • participation in a parallel study
  • any absolute contraindication for deep dry needling
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
10 participants (actual)

Study arms

  • Experimental
    Intervention-DNHS technique

    Dry needling of Myofascial Trigger Points

    Device: DNHS ® (Dry Needling for Hypertonia and Spasticity)

  • Sham comparator
    Control-Sham Dry Needling

    Sham Dry Needling of Myofascial Trigger Points

    Device: Sham Dry Needling

Interventions

  • DeviceDNHS ® (Dry Needling for Hypertonia and Spasticity)

    Dry needling of Myofascial Trigger Points. 2 sessions, one per week, in biceps brachii, brachialis, flexor digitorum superficialis nad profundus, adductor pollicis and first dorsal interossei

  • DeviceSham Dry Needling

    Sham dry needling of Myofascial Trigger Points. 2 sessions, one per week, in biceps brachii, brachialis, flexor digitorum superficialis nad profundus, adductor pollicis and first dorsal interossei

06

What researchers measure

Primary outcomes

  1. Fugl Meyer Assessment Scale (Motor Function)

    Time frame: Two weeks

Secondary outcomes

  1. Modified Ashworth Scale (Hypertonia/Spasticity)

    Time frame: Two weeks

  2. Impact Stroke Scale (Quality of Life)

    Time frame: Two weeks

07

Study locations

1 site
  • San Jorge University
    Villanueva de Gallego, Zaragoza 50830, Spain
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 31, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02291159
Lead sponsor
Universidad San Jorge
Responsible party
Pablo Herrero Gallego (Dr. Pablo Herrero Gallego, Universidad San Jorge) — Principal investigator
First posted
Nov 14, 2014
Start date
Nov 2014
Primary completion
Dec 2014
Completion
Dec 2014
Last update
Dec 31, 2014

Study contacts

Herrero Pablo, Dr.
study director · San Jorge University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion